Founded by Professor Steven L. McKnight, Chairman of Biochemistry at The University of Texas Southwestern Medical Center (UT Southwestern), Peloton Therapeutics represents a unique combination of innovative science, talented researchers, and seasoned investors and management. Working in close collaboration with scientists at UT Southwestern, Peloton is advancing a promising discovery and development pipeline comprised of small-molecule programs, each with a distinct target and mechanism of action. The Company’s vision is to become a major biotech presence in Dallas by leveraging great science, high-caliber people, and the long-term support of Texas-based research institutions.